Cargando…
Evaluation of synergism in drug combinations and reference models for future orientations in oncology
Current cancer therapy includes a variety of strategies that can comprise only one type of treatment or a combination of multiple treatments. Chemotherapy is still the gold standard for cancer therapy, though sometimes associated with undesired side effects and the development of drug resistance. Fo...
Autores principales: | Duarte, Diana, Vale, Nuno |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9127325/ https://www.ncbi.nlm.nih.gov/pubmed/35620200 http://dx.doi.org/10.1016/j.crphar.2022.100110 |
Ejemplares similares
-
New Trends for Antimalarial Drugs: Synergism between Antineoplastics and Antimalarials on Breast Cancer Cells
por: Duarte, Diana, et al.
Publicado: (2020) -
Prediction of Drug Synergism between Peptides and Antineoplastic Drugs Paclitaxel, 5-Fluorouracil, and Doxorubicin Using In Silico Approaches
por: Vale, Nuno, et al.
Publicado: (2022) -
Fasting and Exercise in Oncology: Potential Synergism of Combined Interventions
por: Wilson, Rebekah L., et al.
Publicado: (2021) -
The Role of Dopamine in Repurposing Drugs for Oncology
por: Moura, Catarina, et al.
Publicado: (2023) -
Understanding the Clinical Use of Levosimendan and Perspectives on its Future in Oncology
por: Ribeiro, Eduarda, et al.
Publicado: (2023)